Article
An adenosine deaminase (ADA) allele contains two newly identified deleterious mutations (Y97C and L106V) that interact to abolish enzyme activity.
Human molecular genetics - 1 Dec 1997
Jiang C, Hong R, Horowitz S D, Kong X, Hirschhorn R
Abstract excerpt
Genetic deficiency of the purine salvage enzyme adenosine deaminase (ADA) results in varying degrees of immunodeficiency, ranging from neonatal onset Severe Combined Immunodeficiency (SCID) to an adult onset immunodeficiency disorder. Multiple different mutations have now been identified in these immunodeficient patients. Additional mutations, initially identified in healthy individuals, abolish ADA in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
